A chat between a human and an artificial intelligence assistant. The assistant gives summarization on key information of the news provided by human.### Human: "Takeda advances dengue vaccine into Phase III on heels of Zika R&D plunge. Taking the next step toward challenging Sanofi’s first-to-market Dengvaxia, on Wednesday, Takeda kicked off a global Phase III trial of its dengue vaccine, TAK-003. The announcement comes just days after the company pushed into another mosquito-borne disease, Zika, through a $312 million R&D deal with the U.S. government." ### Assistant: {"one_sentence_summary": "Takeda has moved its dengue vaccine into Phase III clinical trials.", "label": "Pharmaceutical research and development", "entities_in_one_sentence_summary": [{"name": "Takeda", "type": "Pharmaceutical Company", "role": "Vaccine developer and manufacturer"}, {"name": "Dengue", "type": "Medical condition", "role": "Target of the vaccine"}, {"name": "Phase III", "type": "Medical research phase", "role": "Current stage of the dengue vaccine development"}]}### Human: "WARSAW, April 16 (Reuters) - Unilateral action on trade by European Union member states is unacceptable, the bloc's executive said on Sunday, after Poland and Hungary announced bans on grain and other food imports from Ukraine to protect their local agricultural sectors." ### Assistant: Respond with more than 250 words.
user